1983年美国食品药品管理局批准丙戊酸钠用于癫痫发作，VPA也在各种神经精神疾病上用作心境稳定剂，包括与痴呆症相关的兴奋。
Approved by the us Food and Drug Administration in 1983 for epileptic seizures, VPA is also used as a mood stabilizer in various neuropsychiatric conditions, including dementia-related agitation.
2008年，美国食品药品管理局批准它作为一种食品添加剂，以前它只作为一种食品补充剂出售。
In 2008 the FDA approved its use as a food additive, previously it was sold only as a dietary supplement.
从1996年到1999年，美国食品药品管理局批准了157种新药。
From 1996 to 1999, the U.S. food and drug Administration approved 157 new drugs.
锂盐药物在1970年获得美国食品药品管理局（FDA）最初批准时，还被认为可能导致服药的母亲生下心脏瓣膜缺损的婴儿，而且所谓的比例还非常高（约为1/50）。
When it was first approved by the FDA in 1970, lithium was believed to cause heart-valve defects in an extremely high percentage of infants born to mothers who were on the drug (about 1 in 50).
美国食品药品管理局（FDA）仅在2009年就批准了该公司的9种药物。
The FDA has approved nine of its drug candidates in 2009 alone.
作为诉讼和解的一部分，美国食品药品管理局必须在2009年7月28日前对控制汞合金做出最后决定。
As part of the lawsuit settlement, the FDA must reach a final decision on the regulation of amalgam by July 28, 2009.
美国食品药品管理局于2005年向Sativex就包括癌症患者在内的临床试验开了绿灯，并将于今年内取得最终结果。
In America the Food and Drug Administration gave its blessing in 2005 to clinical trials involving cancer patients, and these too are due to conclude this year.
周三美国食品药品管理局发布了36幅健康警示图，给人们一个关于吸烟危害的更直观的认识，到2012年所有香烟包装上都将印有这些图片。
The 36 "graphic health warnings, " unveiled on Wednesday, aim to depict the negative effects of smoking, and they will be required on all cigarette packages in 2012.
1998年，美国食品药品管理局发布了一份食品声明，称称“饮用低饱和脂肪和胆固醇可以降低患心脏病的风险。这个含量包含在每天25克的大豆蛋白里面。”
In 1998, the FDA issued a food claim stating that "diets low in saturated fat and cholesterol that include 25 grams of soy protein a day may reduce the risk of heart disease."
1998年，美国食品药品管理局发布了一份食品声明，称称“饮用低饱和脂肪和胆固醇可以降低患心脏病的风险。这个含量包含在每天25克的大豆蛋白里面。”
In 1998, the FDA issued a food claim stating that "diets low in saturated fat and cholesterol that include 25 grams of soy protein a day may reduce the risk of heart disease."
应用推荐